Brief Title
Quality of Life in Survivors of Gynecologic Cancer
Official Title
Quality of Life of Gynecologic Cancer Survivors
Brief Summary
RATIONALE: Quality-of-life assessment in cancer survivors may help determine the long-term
effects of having had gynecologic cancer and may help improve the quality of life for future
cancer survivors.
PURPOSE: This clinical trial is studying the quality of life in survivors of gynecologic
cancer.
Detailed Description
OBJECTIVES:
- Describe the significant quality of life (QOL) concerns and long term survivorship
issues of women diagnosed and treated for early stage ovarian and endometrial cancer
five or more years ago.
- Identify mechanisms which contribute to a gynecologic cancer survivorship model through
comparison and prediction of high versus low QOL associated with long term adjustment
and survivorship. Examine social support, coping efforts, self-efficacy, meaning
associated with survivorship, performance status, and age at diagnosis as potential
predictors.
- Identify and compare factors that predict high versus low QOL for women with early stage
endometrial cancer completing participation in GOG-99 clinical trial. Conduct
exploratory analysis examining long term QOL concerns of survivors randomized to surgery
arm with or without radiotherapy.
OUTLINE: Patients complete one telephone interview with a professional female interviewer.
The interview lasts approximately 60 minutes and is audiotaped.
PROJECTED ACCRUAL: A total of 197 early stage endometrial cancer survivors and 114 early
stage ovarian cancer survivors will be accrued for this study within 2 years.
Study Type
Observational
Condition
Endometrial Cancer
Intervention
quality-of-life assessment
Publications
* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.
Recruitment Information
Recruitment Status
Procedure
Estimated Enrollment
311
Start Date
April 1999
Primary Completion Date
March 2002
Eligibility Criteria
DISEASE CHARACTERISTICS:
- Histologically confirmed early stage ovarian and endometrial cancer survivors treated
and diagnosed five or more years ago
- Patients completing treatment in GOG-95 or GOG-99 protocols at least 5 years ago with
no recurrence of disease
- Patients with secondary malignancy or under treatment for other medical conditions are
eligible
PATIENT CHARACTERISTICS:
Age:
- Not specified
Performance status:
- Not specified
Life expectancy:
- Not specified
Hematopoietic:
- Not specified
Hepatic:
- Not specified
Renal:
- Not specified
Other:
- Must be capable of completing telephone interview in English
PRIOR CONCURRENT THERAPY:
Biologic therapy:
- See Disease Characteristics
Chemotherapy:
- See Disease Characteristics
Endocrine therapy:
- See Disease Characteristics
Radiotherapy:
- See Disease Characteristics
Surgery:
- See Disease Characteristics
Gender
Female
Ages
N/A - N/A
Accepts Healthy Volunteers
No
Contacts
Lari B. Wenzel, PhD, ,
Location Countries
Canada
Location Countries
Canada
Administrative Informations
NCT ID
NCT00003795
Organization ID
CDR0000066938
Secondary IDs
GOG-9902
Study Sponsor
Gynecologic Oncology Group
Collaborators
National Cancer Institute (NCI)
Study Sponsor
Lari B. Wenzel, PhD, Study Chair, Chao Family Comprehensive Cancer Center
Verification Date
March 2009